Catalyst Wire Dossier Catalyst Wire Dossier

Pimecrolimus-eluting coronary stent system

pimecrolimus · Cordis US Corp.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pimecrolimus-eluting coronary stent system, covering 2013-03-06 to 2013-03-06. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS) [Phase 3]

See pricing